A Phase II Trial Evaluating Irinotecan Plus 5FU/LV in Patients With Relapsed/Refractory Upper GI Tumours

NCT00220064 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Upper Gastrointestinal Tumours

Interventions

DRUG: Irinotecan, 5-Fluorouracil, Leucovorin

Sponsor

Royal Marsden NHS Foundation Trust

Collaborators

[object Object]